baltimore defective drug lawyers, product liability attorneys in maryland, defective product law firm, medication error, side effects, Xarelto lawsuit

Blood Thinner Medication Xarelto is Causing Severe Adverse Reactions

May 6th, 2015

Earlier this year, The Yost Legal Group outlined the underlying factors of a Multidistrict Litigation (MDL) against the blood-thinner medication Xarelto. Since the announcement of this litigation at the end of 2014, a case that already appeared primed to become one of 2015’s largest mass tort drug cases has continued to grow as new patients harmed by this medication continue to come forward.

The case against Xarelto and manufacturer Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, centers on the fact that many patients felt they were not properly warned about the possible risks associated with taking this dangerous medication. In nearly all cases, claimants stated that the medication, which was intended to reduce blood clots and prevent strokes in patients with certain medical conditions, actually ended up causing uncontrollable internal bleeding.

Adverse Drug Reactions to Xarelto Include:

  • Excessive Bleeding
  • Red or Black Stools
  • Frequent Nosebleeds
  • Pink or Brown Urine
  • Unexplained Bruises or Bruises that Increase in Size
  • Coughing up Blood or Blood Clots
  • Vomiting Blood or Vomit that Resembles Coffee Grounds
  • Death
  • Bleeding from the Gums
  • Excessive Menstruation

To make matters worse, there is no known antidote for the serious and potentially deadly side-effects caused by Xarelto. While alternative anti-coagulant medications such as Warfarin can also increase the risk of bleeding problems in some patients, a vast majority of these problems can be treated through the use of Vitamin K and blood transfusions. Unfortunately, for patients experiencing similar side-effects from Xarelto, these techniques have proven to be ineffective. This has caused devastating and occasionally fatal consequences in many patients.

In December of 2014, a judicial panel ruled in favor of consolidating dozens of product liability claims against Xarelto and its manufacturers into one multidistrict litigation based out of the Eastern District Court of Louisiana. This action would allow all pending and future claims against Xarelto to be combined into one mass tort litigation, and would also encourage other patients harmed by the medication to come forward and seek compensation for their physical and emotional damages.

This technique of attracting new cases to the litigation against Xarelto appears to be wildly successful, as lawyers involved in the case are now reporting that they are adding five to ten new claims a week. Since the Multidistrict Litigation was announced in December of 2014, the number of cases against Xarelto has expanded from 21 lawsuits to nearly 200 product liability claims. In May of 2014, pharmaceutical manufacturer Boehringer Ingelheim announced a $650 million settlement in a similar anti-coagulant medication product liability case. The MDL against Xarelto and Janssen Pharmaceuticals may result in a similar or even larger settlement agreement when all is said and done.

If you or a loved one has been harmed or suffered adverse reactions after taking the anti-coagulant medication Xarelto, you will need an experienced legal team to help you. There is a limited time period in which you may file your claim, so call The Yost Legal Group at 1-800-YOST-LAW (967-8529) right away.

The experienced drug litigation lawyers at The Yost Legal Group will help you understand the details of your case and will provide the answers you need. When you call, you will receive a FREE and confidential consultation with an experienced Baltimore, Maryland Medical Malpractice and Product Liability attorney.

When you trust The Yost Legal Group to represent you, there will never be an attorney’s fee unless we achieve a recovery for you.

The Yost Legal Group – Experienced Attorneys Dedicated to Protecting Your Rights

Xarelto Update: First Federal MDL Trial Verdict

The first multi-district litigation (MDL) trial for the blood thinner medication Xarelto began just a few weeks ago. This drug is used to prevent blood clots in patients suffering from arrhythmic heart disorder. If not properly monitored, Xarelto increases the risk of severe internal bleeding. The legal team representing Xarelto victims argues that the manufacturer of the drug failed to properly warn the medical community of the danger of uncontrollable bleeding presented by Xarelto. Sadly,…

Read More »

Manufacturers of Xarelto are Being Investigated for their Marketing Strategies

Drug companies Janssen Pharmaceutical, a subsidiary of Johnson & Johnson, and Bayer Healthcare are being investigated by attorneys for their marketing strategies. For the blood-thinning drug Xarelto (rivaroxaban), these strategies were aimed at putting profits over safety. Even though Xarelto was said to surpass all other drugs of its kind in effectiveness, safety and ease of use, it turned out to be life-threatening for many users. Xarelto, approved by the FDA in 2011, was prescribed…

Read More »

Blood-Thinner Drug Xarelto Markets Convenience, But Puts Patients In Grave Danger defective drug lawyers baltimore, xarelto lawsuit, maryland product liability law firm, consumer safety

One of the first major drug torts of 2015 will center on the controversial anticoagulant medication known as Xarelto. Manufactured by Johnson & Johnson subsidiary Janssen Pharmaceuticals as well as Bayer Corporation, Xarelto is part of a new breed of blood thinning drugs known as New Oral Anti-Coagulants (NOACs).   What’s new is that unlike the longstanding go-to drug Coumadin (Warfarin), this new generation of drugs promises the convenience of freedom from dietary restrictions and the…

Read More »